baber/WOPTO huggingface dataset:
Patent JP-2550454-B2 (JP)
IPC: G01N33/76
Filed: 1991-03-29
Granted: 1996-11-06
Abstract: An assay procedure for predicting the onset of the ovulation in a human subject. Urine samples are obtained on consecutive days and assayed for total gonadotropal alpha peptide chain content. The alpha chain content surges to indicate ovulation and the onset of the fertile period.
Patent JP-3015383-B2 (JP)
IPC: C12N15/09
Filed: 1988-09-08
Granted: 2000-03-06
Abstract: Fibroblasts transduced with genetic material encoding a polypeptide or protein of interest and, optionally, a selectable marker, as well as methods for making and using the transduced fibroblasts. Such fibroblasts are useful in delivering the encoded polypeptide or protein, such as an enzyme, a hormone or a drug, to an individual who has had a graft or implant of the transduced cells.
Patent JP-3556670-B2 (JP)
IPC: A61B19/00
Filed: 1994-09-06
Granted: 2004-08-18
Abstract: A valve (1) comprises an outer ring (5,6) and a sealing sleeve (7) of flexible material mounted to the ring (5,6) and extending into the opening defined by the ring to terminate in a substantially centrally disposed inlet opening (8). Through the opening (8) a member such as a trocar (3) or surgical instrument may be passed. The sealing sleeve (7) remains in sealing engagement with the member (3) as it is passed therethrough. <IMAGE>
Patent JP-2653722-B2 (JP)
IPC: G01N33/536
Filed: 1990-06-12
Granted: 1997-09-17
Abstract: A low cost optical system which incorporates a low ultraviolet output tungsten halogen light source and solid state photodetectors and circuitry in such a way as to provide reliable fluorometric test results. The attainment of reliable results using such components is made possible by incorporating highly ultraviolet transmissive optics to maximize ultraviolet light throughput and by using solid state circuitry together with a filter wheel having both light blocking and light passing regions in a manner which fully accounts for noise and dark signals associated with solid state photodetectors.
Patent JP-3150149-B2 (JP)
IPC: A61P9/12
Filed: 1992-04-10
Granted: 2001-03-26
Abstract: A class of 1-arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds is described for use in treatment of circulatory disorders such as hypertension. Compounds of particular interest are angiotensin II antagonists of the formula <CHEM>  wherein A is selected from <CHEM> wherein m is one; wherein R<1> is selected from ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, benzyl, cyclohexyl, cyclohexylmethyl, 2-butenyl, 3-butenyl, 2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein R<2> is selected from ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, 4-methylbutyl, tert-butyl, n-pentyl, neo-pentyl, 1-oxoethyl, 1-oxopropyl, 1-oxobutyl, 1-oxopentyl, 1,1-dimethoxypropyl, 1,1-dimethoxypentyl, halo, difluoromethyl, 1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 1,1-difluoro-2-cyclohexylethyl, 2-cyclohexylethyl, 1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl, 1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 1,1-difluoropentyl, benzyl, 2-phenylethyl, 1,1-difluoro-3-phenylpropyl, cyclohexylmethyl, cyclohexanoyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-butynyl, 2-butynyl, 3-butynyl, propylthio and butylthio; wherein each of R<3>, R<4>, R<6> through R<1><1> is hydrido and R<5> is selected from COOH, SH, PO3H2, SO3H, CONHNH2, CONHNHSO2CF3, OH, <CHEM> wherein each of R<4><2> and R<4><3> is independently selected from chloro, cyano, nitro, trifluoromethyl, methoxycarbonyl and trifluoromethylsulfonyl.
Patent JP-3822233-B2 (JP)
IPC: C07C251/40
Filed: 1994-09-26
Granted: 2006-09-13
Abstract: Processes are disclosed which are useful for the preparation of a substantially pure compound of formula (3), wherein R6 and R7 are each hydrogen or R6 and R7 are independently selected from (i), wherein Ra and Rb are independently selected from hydrogen, loweralkyl and phenyl and Rc, Rd and Re are independently selected from hydrogen, loweralkyl, trifluoromethyl, alkoxy, halo and phenyl; and (ii) wherein the naphthyl ring is unsubstituted or substituted with one, two or three substituents independently selected from loweralkyl, trifluoromethyl, alkoxy, and halo; or R6 is as defined above and R7 is R7aOC (O)- wherein R7a is loweralkyl or benzyl; or R6 and R7 taken together with the nitrogen atom to which they are bonded are (a) or (b), wherein Rf, Rg, Rh and Ri are independently selected from hydrogen, loweralkyl, alkoxy, halogen, and trifluoromethyl and R8 is hydrogen or -C(O)R'' wherein R'' is loweralkyl, alkoxy, benzyloxy or phenyl wherein the phenyl ring is unsubstituted or substituted with one, two or three substituents independently selected from loweralkyl, trifluoromethyl, alkoxy and halo; or an acid addition salt thereof. <CHEM>   <CHEM>   <CHEM>
Patent JP-4271265-B2 (JP)
IPC: B01D67/00
Filed: 1998-08-25
Granted: 2009-06-03
Abstract: A leukocyte-removing filter medium for removing leukocytes from a leukocyte-containing fluid, wherein said filter medium has, at least on its surface, hydrophilic basic groups containing at least one nonionic hydrophilic portion and at least one basic portion, in which said hydrophilic portion(s) is located nearer to the end of the hydrophilic basic group than said basic portion(s) is. <IMAGE>
Patent JP-3614861-B2 (JP)
IPC: F02G1/055
Filed: 1995-12-06
Granted: 2005-01-26
Abstract: PCT No. PCT/DE95/01731 Sec. 371 Date Jun. 9, 1997 Sec. 102(e) Date Jun. 9, 1997 PCT Filed Dec. 6, 1995 PCT Pub. No. WO96/18029 PCT Pub. Date Jun. 13, 1996A device (1) has a drive (2) with a gas chamber 93), a plate (4) moveably disposed therein, a heater (5), a cooler (8) and a regenerator (11). An auxiliary drive (14) can move the plate (4) without driving the machine (13). The plate (4) may thus advantageously be moved with little force, and the device (1) may be modified in a simple manner to permit a automatic start of the device through exposure to the sun.
Patent JP-3212613-B2 (JP)
IPC: F24F5/00
Filed: 1996-11-01
Granted: 2001-09-25
Abstract: In order to cool a room, a cooling element fitted in the ceiling region is cooled to below the freezing point, preferably to about -40 DEG  C., during the cooling phases so that condensate forming thereon freezes immediately. During regeneration phases when the room is not in use, the cooling element is defrosted and the melted condensate is caught in a condensate tray beneath the cooling element and drained via a discharge. The great temperature difference between the room to be cooled and the cooling element also makes it possible to obtain a strong cooling effect with a small cooling element, especially by indirect radiation exchange between the room and the cooling element via an intermediate ceiling. In addition, the air in the room is dehumidified since water vapour is deposited on and bonded to the cooling element in the form of ice. Moreover, the cooling element itself is supported by a tray and a stand upon a floor, and detachable from the floor so that the cooling element is capable of being relocated to different locations.
Patent JP-3216885-B2 (JP)
IPC: A61P25/18
Filed: 1997-01-15
Granted: 2001-10-09
Abstract: Substituted 1-arylphthalazine compositions with the formula wherein R1, R2, R3 and R4 are independently a) H, b) HO, c) R11O-, d) halogen, e) C1-C3-alkyl, f) CF3, g) R12CO2-, or h) R12CONH-; R1 and R2, or R2 and R3, or R3 and R4 can be taken together to be a) -OCH2O-, or b) -OCH2CH2O-; R5 is a) H, b) C1-C6-alkyl, c) C3-C6-alkenyl, d) C3-C6-alkynyl, e) C3-C6-cycloalkyl, f) phenyl or substituted phenyl, wherein the phenyl is substituted with one or two substituents selected from the group consisting of C1-C3-alky, halogen, R12HN-, R12O-, CF3-, R13SO2- and CO2R12, or g) phenyl-C1-C3-alkyl or substituted phenyl-C1-C3-alkyl, wherein the phenyl is substituted with one or two substituents selected from the group consisting of C1-C3-alkyl, halogen, R12HN-, R12O-, CF3-, R13SO2- and -CO2R12; R6 is a) R10R11N-, b) R10NHC(NH)-, c) R12CONH-, d) 1-pyrrolidino or e) 1-piperidino; R7 is H; R8 and R9 are independently a) H, b) C1-C3-alkyl, c) halogen, d) R12O-, e) CF3-, or f) -CO2R12; R10 and R11 are independently a) H, b) C1-C10-alkyl, c) C1-C6-perfluoroalkyl, d) C3-C10-alkenyl, e) C3-C10-alkynyl, or f) C3-C6-cycloalkyl; R12 is H or C1-C3-alkyl; and R13 is C1-C3-alkyl or CF3; and pharmaceutically acceptable salts thereof,
Patent JP-3244709-B2 (JP)
IPC: F16K3/20
Filed: 1997-02-28
Granted: 2002-01-07
Abstract: Single-plate slide, especially single-plate pipe bridge slide (10) with a slide-plate (16) and if necessary a pipe bridge (20), which is or are movable by means of an actuating device (18, 19) within this casing (11) in order to close or open a fluid passage (17) formed in a casing (11), the slide plate (16) or pipe bridge (20) having lateral seal surfaces which correspond with seal surfaces located on the casing side, especially annular seal surfaces (14, 15). At least one of the seal surfaces (14, 15) on the casing side forms part of a seal ring (23) located in the casing (11), which abuts with resilient pre-stressing on the facing seal surface of the slide plate (16) or pipe bridge (20).
Patent JP-4554728-B2 (JP)
IPC: A61P37/08
Filed: 1998-03-05
Granted: 2010-09-29
Abstract: Pharmaceutical or food composition comprises an appropriate vehicle, a heat shock protein and at least one conformational or sequential epitope of an antigenic structure inducing a graft versus host, an allergic, or an auto-immune reaction.
Patent JP-3598305-B2 (JP)
IPC: A61M25/02
Filed: 1998-03-23
Granted: 2004-12-08
Abstract: An intravenous site protection device is formed with a rigid, elongated top member and a rigid, elongated bottom member which are oppositely secured on a patient's extremities. The top member is configured to accommodate a catheter and supply tubing to prevent accidental dislodgement during transportation or movement of the patient. Securing straps maintain the top and bottom members against the extremity of the wearer and a resilient sponge is positioned beneath the top member, against the wearer's skin, to assure proper circulation to the intravenous site. The rigid plastic ensures protection of the intravenous site should the site be struck or contacted with clothing or other articles during intravenous fluid transfer. The preferred form of the invention is made from a transparent plastic to allow ease in monitoring by medical personnel.
Patent ES-2168958-B2 (ES)
Title: Jaula expositora
Inventor: MONSALVEZ SORIANO GLORIA
IPC: B65D19/38
Filed: 2000-04-13
Granted: 2003-05-01
Abstract: Jaula expositora concebida especialmente para ser utilizada en el transporte y exposición de plantas y que tiene como finalidad permitir su apilamiento para facilitar el transporte, reducir su ocupación volumétrica tanto en su almacenaje como en su transporte en vacío y permitir además un fácil montaje y desmontaje de la misma así como su manipulación con las palas de una carretilla elevadora. Está constituida básicamente por una plataforma base (1), materializada en un palet convencional de madera, guías verticales para el acoplamiento (4) que permiten enchufar verticalmente los paneles frontal (6) y trasero (6'') y unos listones verticales (8) sobresalientes con respecto a la superficie superior de la base (1) destinados a la retención de los respectivos paneles (6'', 6'''' y 6'''''') de la jaula. Dichos paneles (6'', 6'''' y 6'''''') están acoplados mediante bisagras a modo de pletinas (9) para permitir su articulación y plegado a la hora del desmontaje.
Patent ES-2214078-B2 (ES)
Title: Aparato de control de inyeccion de combustible.
Inventor: KENICHI MACHIDA
IPC: G05D7/06
Filed: 2001-06-05
Granted: 2005-10-01
Abstract: Aparato de control de inyección de combustible. El aparato permite que un motor desarrolle una alta potencia mediante una inyección de combustible, basándose en que: una calculadora de coeficiente corrector de velocidad del vehículo 26, calcula un coeficiente corrector de combustible KVPLS, basándose en la velocidad del vehículo VPLS; una calculadora de coeficiente corrector de válvula de admisión 27, calcula un coeficiente corrector KVOTH, basándose en la abertura de la válvula de admisión OTH; un multiplicador de coeficiente corrector 28, multiplica el coeficiente corrector KVPLS y el coeficiente corrector KVOTH, calculando así un coeficiente corrector de ajuste de combustible a velocidad del vehículo KVAF; una calculadora de tiempo de inyección 30, calcula un tiempo básico de inyección TiM, basándose en la abertura de la válvula OTH y la velocidad rotacional del motor Ne, calculando un tiempo de inyección de combustible Ti, leyendo el coeficiente corrector KVAF y corrigiendo el tiempo básico de inyección TiM.
Patent ES-2498790-B2 (ES)
Title: Procedimiento para la detección magneto-electroquímica sin lavados de un analito en una muestra
Inventor: HERNANDEZ SANTOS DAVID
IPC: G01N33/58
Filed: 2013-03-20
Granted: 2015-06-25
Abstract: La invención describe un procedimiento rápido, simple y eficaz para la detección magneto-electroquímica de un analito en una muestra eliminando todo paso de lavado, que comprende la incubación de dicha muestra en presencia de partículas magnéticas y de un elemento de reconocimiento ligado a un enzima en que dicho elemento de reconocimiento y dichas partículas magnéticas son capaces de interaccionar independientemente con dicho analito, la aplicación del electrodo al resultado de esta etapa de incubación en presencia de al menos un imán, la adición de un sustrato electroquímico de dicho enzima para obtener un compuesto con capacidad óxido-reductora, la medición electroquímica en la superficie del electrodo de dicho compuesto con capacidad óxido-reductora o de al menos un producto de una reacción redox generada por dicho compuesto en presencia de los componentes de la muestra, los reactivos añadidos en la incubación y del sustrato electroquímico, y la determinación de la presencia del analito evaluando el resultado de la etapa anterior respecto de una referencia.
Patent ES-2539416-B2 (ES)
Title: Procedimiento para la eliminación bacteriana de nitrato en aguas residuales y sistema biológico electrogénico
Inventor: SALAS RODRIGUEZ JUAN JOSÉ
IPC: C02F3/30
Filed: 2013-12-30
Granted: 2016-01-05
Abstract: Procedimiento para la eliminación bacteriana de nitrato en aguas residuales en un sistema biológico electrogénico y sistema biológico electrogénico para eliminar nitrato. En el procedimiento, el influente se vierte en una cámara anaerobia (1), se circulan las aguas de la cámara anaerobia (1) a una cámara anóxica (3), de dicha cámara anóxica (3) a una cámara aerobia (4), de dicha cámara aerobia (4) a un decantador (5), se recirculan las aguas del decantador (5) a la cámara anaerobia (1) y se recoge el efluente de salida del decantador (5), donde un electrodo de cassette situado en la cámara anóxica (3) es polarizado a un voltaje de  600 mV por un potenciostato (6), que conecta dicho electrodo de cassette con el electrodo de cassette situado en la cámara aerobia (4).
Patent AU-2002221860-B2 (AU)
Title: Nutritional composition for an immune condition
Inventor: HASCHKE FERDINAND
IPC: A23L33/00
Filed: 2001-11-14
Granted: 2006-08-10
Abstract: A nutritional composition is described for prevention or treatment of an immune condition. The composition includes at least vitamin E, vitamin C, vitamin B6, folic acid, vitamin B12, copper, zinc, selenium, fructo-oligosaccharides and/or gum acacia, a probiotic lactic acid bacterium. For example, in an embodiment it comprises per 300 g: 150 IU Vitamin E, 120 mg Vitamin C, 2 mg Vitamin B6, 400 ug Folic acid, 3.8 ug Vitamin B12, 1.5 mg Copper, 15 mg Zinc, 100 ug Selenium, 3 g Fructo-oligosaccharides and/or gum acacia, 10E10 cfu ST11 lactobacillus. Also disclosed are a method for making the nutritional composition, a method for manufacturing a functional food or medicament; and a method of prevention or treatment of an immune condition by administering an effective amount of the composition, functional food or medicament.
Patent AU-2002234892-B2 (AU)
Title: Water-soluble triazole fungicide
Inventor: MORI MAKOTO
IPC: C07D521/00
Filed: 2002-02-20
Granted: 2005-01-06
Abstract: A triazole compound of the general formula (I) or a pharmacologically acceptable salt thereof: <CHEM> Äwherein,  X represents a group of formula X-OH which has antifungal activity, L represents a -(adjacently substituted C6-C10 aryl)-CH2-group and the like, and R represents a -P(=O) (OH)2 group and the like.
Patent AU-2002249518-B2 (AU)
Title: Method and device for calculating a price for using a specific link in a network
Inventor: KENYON CHRISTOPHER M
IPC: G06Q40/00
Filed: 2002-04-02
Granted: 2006-08-10
Abstract: The invention relates to a method for calculating in a network that comprises links, a price for using a specific link in the network. The method comprises the following steps: a) a comparison step for determining a price difference between the price for using the specific link and the price for using instead of the specific link an alternative path in the network, which does not comprise the specific link, b) a change-calculation step for determining a link-price change in the price for using the specific link, and a link-price change in the price for using the links in the alternative path, in response to the determined price difference, c) a combination step for combining for the specific link the determined link-price changes on the price for using the specific link from all links in the network, to determine a total price-change for the specific link, d) a merging step for merging the determined total price-change with a market-induced price change in the price for using the specific link, to calculate the price for using the specific link, wherein the market-induced price change is being driven by at least one random variable.
Patent AU-2002314688-B2 (AU)
Title: Novel surface exposed immunoglobulin D-binding protein from moraxella catarrhalis
Inventor: JANSON HAKAN
IPC: C07K16/12
Filed: 2002-07-01
Granted: 2007-09-20
Abstract: The present invention relates to a surface exposed protein, which can be detected in Moraxella catarrhalis, having an amino acid sequence as described in SEQ ID NO: 1, an apparent molecular weight of 200 kDa and a capacity of selectively binding membrane bound or soluble IgD, to an immunogenic or IgD-binding fragment of said surface exposed protein, and to an immunogenic and adhesive fragment of said surface exposed protein. DNA segments, vaccines, plasmids and phages, non human hosts, recombinant DNA molecules and plants, fusion proteins and polypeptides and fusion products are also described. A method of detecting IgD, a method of separating IgD, a method of isolation of a surface exposed protein of Moraxella catarrhalis and a method for treatment of an autoimmune disease are also disclosed.
Patent AU-2002321130-B2 (AU)
Title: Process for activation of drugs in a vibrational mill
Inventor: BRESCIANI MASSIMO
IPC: A61K9/14
Filed: 2002-06-27
Granted: 2006-11-09
Abstract: A process is described for the activation (increase in solubility and bioavailability) of drugs. The process, carried out in a vibrational mill, is characterised by the use of given proportions between the physical mixture made up of drug and pharmaceutical carrier and the empty volume among the grinding means contained inside the mill. The process leads to obtaining powders for pharmaceutical use in which the drug has a high and constant degree of activation; this result is obtainable irrespective of the nature of the drug and carrier used, and of their weight ratio.
Patent AU-2002321403-B2 (AU)
Title: Silencing device and method for needleless syringe
Inventor: KENDALL MARK ANTHONY FERNANCE
IPC: A61M5/24
Filed: 2002-07-25
Granted: 2007-10-04
Abstract: The invention provides a silencer and silencing method which ensures adequate silencing with no deleterious increase in back pressure (which creates a lift-off force) or decrease in device performance. Pressurised gas is supplied to a driver chamber by a bleed-hole having an effective bleed-hole area and, during use of the device for particle delivery, gas is vented to the atmosphere via a silencer having an effective venting area. The bleed-hole area and venting area are chosen to ensure that the mass flow rate of gas through the effective venting area is substantially equal to or greater than the mass flow rate of gas through the effective bleed-hole area. This ensures that there is no build up of gas in the silencer device which tends to increase back pressure and hence lift-off force. Preferred embodiments of the device comprise a silencer having a large volume and a small particle exit opening. Further, there is disclosed an embodiment using one or more transfer ducts to assist particle mixing.
Patent AU-2002355159-B2 (AU)
Title: Anthocyanin derivatives treated with an aluminum salt as food colouring substances
Inventor: SONDERGAARD CLAUS
IPC: A23L1/275
Filed: 2002-07-11
Granted: 2008-01-24
Abstract: A process for modifying the taste and/or odour properties of a food colouring substance having unpleasant taste and/or odour properties is disclosed. Secondly, there is provided a process for obtaining a blue non-bleeding colour that seems approvable by most health authorities. The invention is useful in food products, sweets and pharmaceutical products ingested orally.
Patent AU-2002363312-B2 (AU)
Title: A paint roller
Inventor: ER POH LEONG
IPC: B05C17/025
Filed: 2002-10-15
Granted: 2007-02-01
Abstract: A paint roller ( 10 ) has a paint applicator ( 12 ), two holder mounts an applicator holder ( 14 ). The paint applicator ( 12 ) has a cylindrical outer surface and two opposite ends ( 18 a ,18 b). The two holder mounts, respectively associated with the two opposite ends ( 18 a , 18 b), each has a base surface ( 24 ) and a journal ( 26 ) that protrudes from the surface ( 24 ) away from the paint applicator ( 12 ). The applicator holder ( 14 ) has a handle ( 40 ) and a fork ( 42 ) with opposite sides ( 44,48 ) that each has a journal engagement portion ( 48,50 ). In a preferred embodiment, each of the holder mounts has holder abutments, ( 30 ) that protrude from the surface ( 24 ) away from the paint applicator ( 12 ). In an alternate embodiment, the applicator holder ( 14 ) has applicator abutments that protrude from mount abutment surfaces of each of two journal engagement portions towards the paint applicator ( 12 ).
Patent AU-2003238041-B2 (AU)
Title: Opalescent glass-ceramic product
Inventor: KRUMBHOLZ KLAUS
IPC: C03C10/10
Filed: 2003-06-24
Granted: 2008-07-03
Abstract: An opalescent glass-ceramic product, especially for use as a dental material or as an additive to or component of dental material, including SiO<SUB>2</SUB>, Al<SUB>2</SUB>O<SUB>3</SUB>, P<SUB>2</SUB>O<SUB>5</SUB>, Na<SUB>2</SUB>O, K<SUB>2</SUB>O, CaO and Me(IV))O<SUB>2</SUB>. In order to obtain improved opalescence with improved transparency, in addition to fluorescence, thermal expansion and a combustion temperature adapted to other materials, the opalescent ceramic product is completely or substantially devoid of ZrO<SUB>2 </SUB>and TiO<SUB>2</SUB>, such that the Me(II)O content in the glass ceramic is less than approximately 4 wt % and the Me(IV)O<SUB>2 </SUB>content amounts to approximately 0.5-3 wt %. The invention also relates to a method for the production of the opalescent glass-ceramic product.
Patent AU-2003246931-B2 (AU)
Title: Monitoring of cells
Inventor: GERSHATER CRAIG J L
IPC: B01L3/00
Filed: 2003-07-09
Granted: 2007-01-25
Abstract: A method for monitoring cells in a microfluidic-device, wherein the device includes a chamber comprising a sensor, and the monitoring is under conditions such that attachment of cells to the surface of the chamber is inhibited.